Philip A. Linden
Papers
8
Total Citations
109
H-Index
6
About
Philip A. Linden is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for esophageal and lung cancers. His major contributions lie in demonstrating the superiority of robotic and minimally invasive esophagectomy (MIE) over traditional open surgery, showing that these approaches yield better lymphadenectomy, clearer surgical margins, and improved long-term survival. His 2020 propensity-matched analysis of the National Cancer Database, with 13 citations, was pivotal in establishing MIE’s oncologic benefits. Linden also investigates the role of hospital volume in robotic esophagectomy outcomes (19 citations) and the impact of healthcare policy on surgical access, notably showing that Affordable Care Act Medicaid expansion increased utilization of minimally invasive lung resection for early-stage cancer. His 2021 study on robotic mediastinal tumor resection (36 citations) highlights improved outcomes for complex cases. Beyond technique, Linden examines diagnostic accuracy, as in the NAVIGATE study on biopsy tools and rapid on-site evaluation. With a career dedicated to evidence-based surgical innovation, Linden’s work informs both clinical practice and health policy, making him a key figure in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8